| For: | Tejeda-Maldonado J, García-Juárez I, Aguirre-Valadez J, González-Aguirre A, Vilatobá-Chapa M, Armengol-Alonso A, Escobar-Penagos F, Torre A, Sánchez-Ávila JF, Carrillo-Pérez DL. Diagnosis and treatment of hepatocellular carcinoma: An update. World J Hepatol 2015; 7(3): 362-376 [PMID: 25848464 DOI: 10.4254/wjh.v7.i3.362] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v7/i3/362.htm |
| Number | Citing Articles |
| 1 |
Jingyue Yang, Bo Qiu, Xiao Li, Hongmei Zhang, Wenchao Liu. p53-p66shc/miR-21-Sod2 signaling is critical for the inhibitory effect of betulinic acid on hepatocellular carcinoma. Toxicology Letters 2015; 238(3) doi: 10.1016/j.toxlet.2015.07.016
|
| 2 |
Diwakar Suresh, Akshatha N. Srinivas, Bharathwaaj Gunaseelan, S.A. Amith Bharadwaj, Manju Moorthy, Gopalkrishna Ramaswamy, Suchitha Satish, Prashant Vishwanath, Prasanna Kumar Santhekadur, Saravana Babu Chidambaram, Divya P. Kumar. Targeting AATF reprograms the tumor microenvironment and suppresses hepatocellular carcinoma via MIR100HG-TGF-β signaling. Molecular Therapy Oncology 2026; 34(3) doi: 10.1016/j.omton.2026.201259
|
| 3 |
Guo‐Qiang Zhang, Weiwei Feng, Zhiyuan Gao, Gao‐Lan Zhang, Xinying Wu, Yating Xiao, Xun Li, Lei Zheng, Dan Ding, Jianshuang Guo, Bo Situ. A NIR ratiometric fluorescent biosensor for sensitive detection and imaging of α‐L‐fucosidase in living cells and HCC tumor‐bearing mice. Aggregate 2023; 4(2) doi: 10.1002/agt2.286
|
| 4 |
Chengxu Ruan, Lijuan You, Yingdong Qiu, Xiao Cui, Defeng Wu. Tubeimoside I induces autophagy in HepG2 cells by activating the AMP‑activated protein kinase signaling pathway. Oncology Letters 2020; 20(1) doi: 10.3892/ol.2020.11604
|
| 5 |
Jia-yan Ni, Jian Kong, Hong-liang Sun, Yao-ting Chen, Jiang-hong Luo, Wei-dong Wang, Dong Chen, Xiong-ying Jiang, Lin-feng Xu. Prognostic Factors for Survival After Transarterial Chemoembolization Combined with Sorafenib in the Treatment of BCLC Stage B and C Hepatocellular Carcinomas. Academic Radiology 2018; 25(4) doi: 10.1016/j.acra.2017.10.018
|
| 6 |
Li Zhang, Jiasheng Chen, Chunming Gao, Chuanmiao Liu, Kuihua Xu. An efficient model for auxiliary diagnosis of hepatocellular carcinoma based on gene expression programming. Medical & Biological Engineering & Computing 2018; 56(10) doi: 10.1007/s11517-018-1811-6
|
| 7 |
Hong‐Xu Zhu, Wen‐Jie Lu, Wei‐Ping Zhu, Song Yu. Comprehensive analysis of N6‐methyladenosine‐related long non‐coding RNAs for prognosis prediction in liver hepatocellular carcinoma. Journal of Clinical Laboratory Analysis 2021; 35(12) doi: 10.1002/jcla.24071
|
| 8 |
Adithya Jayaprakash Kamath, Siva S., Abir Chakraborty, Saraswathy R., Aswathy R. Devan, Gowri Rajesh, Nikhil K. Haridas, Pavithran K., Gautam Sethi, Lekshmi. R. Nath. Molecular Precision Medicine in Cancer. Cancer Drug Discovery and Development 2026; doi: 10.1007/978-3-032-24071-2_3
|
| 9 |
Jian-Jun Gao, Zhen-Yan Shi, Ju-Feng Xia, Yoshinori Inagaki, Wei Tang. Sorafenib-based combined molecule targeting in treatment of hepatocellular carcinoma. World Journal of Gastroenterology 2015; 21(42): 12059-12070 doi: 10.3748/wjg.v21.i42.12059
|
| 10 |
Mahfoozur Rahman, Kainat Alam, Rafida Ilyas, Sarwar Beg. Nanoformulation Strategies for Cancer Treatment. 2021; doi: 10.1016/B978-0-12-821095-6.00015-X
|
| 11 |
Da-wei Sun, Ying-yi Zhang, Xiao-dong Sun, Yu-guo Chen, Wei Qiu, Min Ji, Guo-yue Lv. Prognostic value of cytokeratin 19 in hepatocellular carcinoma: A meta-analysis. Clinica Chimica Acta 2015; 448 doi: 10.1016/j.cca.2015.06.027
|
| 12 |
Yingru Zhi, Mubalake Abudoureyimu, Hao Zhou, Ting Wang, Bing Feng, Rui Wang, Xiaoyuan Chu. FOXM1-Mediated LINC-ROR Regulates the Proliferation and Sensitivity to Sorafenib in Hepatocellular Carcinoma. Molecular Therapy - Nucleic Acids 2019; 16 doi: 10.1016/j.omtn.2019.04.008
|
| 13 |
Yantian Xu, Yuanwen Zheng, Hongyan Liu, Tao Li. Modulation of IGF2BP1 by long non-coding RNA HCG11 suppresses apoptosis of hepatocellular carcinoma cells via MAPK signaling transduction. International Journal of Oncology 2017; 51(3) doi: 10.3892/ijo.2017.4066
|
| 14 |
Giuseppe Tarantino, Paolo Magistri, Roberto Ballarin, Raffaele Di Francia, Massimiliano Berretta, Fabrizio Di Benedetto. Oncological Impact of M-Tor Inhibitor Immunosuppressive Therapy after Liver Transplantation for Hepatocellular Carcinoma: Review of the Literature. Frontiers in Pharmacology 2016; 7 doi: 10.3389/fphar.2016.00387
|
| 15 |
Yitian Qi, Yi Hou, Liangchen Qi.
miR-30d-5p represses the proliferation, migration, and invasion of lung squamous cell carcinoma via targeting
DBF4
. Journal of Environmental Science and Health, Part C 2021; 39(3) doi: 10.1080/26896583.2021.1926855
|
| 16 |
Yukimasa Makita, Shumpei Murata, Yoshiki Katou, Kuniko Kikuchi, Hiroshi Uejima, Mika Teratani, Yasutaka Hoashi, Eriya Kenjo, Satoru Matsumoto, Masahiro Nogami, Kentaro Otake, Yuji Kawamata. Anti-tumor activity of KNTC2 siRNA in orthotopic tumor model mice of hepatocellular carcinoma. Biochemical and Biophysical Research Communications 2017; 493(1) doi: 10.1016/j.bbrc.2017.08.088
|
| 17 |
Hisashi Nakayama, Tadatoshi Takayama. Management before hepatectomy for hepatocellular carcinoma with cirrhosis. World Journal of Hepatology 2015; 7(20): 2292-2302 doi: 10.4254/wjh.v7.i20.2292
|
| 18 |
Xiaoxiao Qin, Xiaojun Hu, Chun Wu, Mingyue Cai, Zhengran Li, Lina Zhang, Liteng Lin, Wensou Huang, Kangshun Zhu. Hepatocellular Carcinoma Cells Carrying a Multimodality Reporter Gene for Fluorescence, Bioluminescence, and Magnetic Resonance Imaging In Vitro and In Vivo. Academic Radiology 2016; 23(11) doi: 10.1016/j.acra.2016.07.009
|
| 19 |
Eric Waidely, Abdul-Rahman Obaid Al-Yuobi, A. S. Bashammakh, Mohammad S. El-Shahawi, Roger M. Leblanc. Serum protein biomarkers relevant to hepatocellular carcinoma and their detection. The Analyst 2016; 141(1) doi: 10.1039/C5AN01884F
|
| 20 |
Manaf Alsudaney, Walid Ayoub, Kambiz Kosari, Ekaterina Koltsova, Mohammed N. Abdulhaleem, Hasmik Adetyan, Tamar Yalda, Abdelrahman M. Attia, Jessica Liu, Ju Dong Yang. Pathophysiology of liver cirrhosis and risk correlation between immune status and the pathogenesis of hepatocellular carcinoma. Hepatoma Research 2025; doi: 10.20517/2394-5079.2024.141
|
| 21 |
Mohamed N. Gomaa, Ahmed M. Abdelmaguid, Bassant E. Samier, Sama E. Ashour, Maya M. El-Demardash, Toka M. Metwally, Mariam S. Hammam, Marwa M. Hussein, Sara A. Mekkawy, Ahmed Abdel Moneim. Mesenchymal Stem Cell-Derived Exosomes: Emerging Therapeutic Strategies for Liver Diseases and Cancer. Science and Technology Nexus 2026; 2 doi: 10.25259/STN_26_2025
|
| 22 |
Qi-Zhe Gong, Di Xiao, Gui-Yi Gong, Jian Xu, Xiao-Dong Wen, Feng Feng, Wei Qu. EH-42: A Novel Small Molecule Induces Apoptosis and Inhibits Migration and Invasion of Human Hepatoma Cells through Suppressing STAT3 Signaling Pathway. Current Cancer Drug Targets 2019; 19(7) doi: 10.2174/1568009619666181226094814
|
| 23 |
Kika Anyiwe, Yao Qiao, Prithwish De, Eric M. Yoshida, Craig C. Earle, Hla‐Hla Thein. Effect of socioeconomic status on hepatocellular carcinoma incidence and stage at diagnosis, a population‐based cohort study. Liver International 2016; 36(6) doi: 10.1111/liv.12982
|
| 24 |
Vivian Y. Ooi, Ting-Yu Yeh. Recent Advances and Mechanisms of Phage-Based Therapies in Cancer Treatment. International Journal of Molecular Sciences 2024; 25(18) doi: 10.3390/ijms25189938
|
| 25 |
Xiang You, Bingyu Huang, Jin Chen, Zhengyu Lin. Application of respiratory sensing technique in CT-guided radiofrequency ablation of liver malignancies. Journal of Cancer Research and Therapeutics 2023; 19(4) doi: 10.4103/jcrt.jcrt_303_23
|
| 26 |
Alireza Hashemzadeh, Yasir Qasim Almajidi, Maher Abdulrazzaq Al-Hakeem, Chou-Yi Hsu, Prakhar Tomar, Ahmed Hjazi, Wesam R. Kadhum, Abdul_Kareem Nasir, Hayder Ridha-Salman, Mohammad Ehsan Taghavizadeh Yazdi. Polyphenol-functionalized metal-organic frameworks: A strategic platform for advanced cancer drug delivery and synergistic therapy. Materials Research Bulletin 2026; 194 doi: 10.1016/j.materresbull.2025.113778
|
| 27 |
Xingqing Jia, Shuangqin Wei, Wujun Xiong, Muhammad Wasim Khan. CXCL5/NF-κB Pathway as a Therapeutic Target in Hepatocellular Carcinoma Treatment. Journal of Oncology 2021; 2021 doi: 10.1155/2021/9919494
|
| 28 |
Baoguo Li, Rui Mao, Changfu Liu, Weihao Zhang, Yong Tang, Zhi Guo. LncRNA FAL1 promotes cell proliferation and migration by acting as a CeRNA of miR-1236 in hepatocellular carcinoma cells. Life Sciences 2018; 197 doi: 10.1016/j.lfs.2018.02.006
|
| 29 |
Kanchan Vishnoi, Rong Ke, Navin Viswakarma, Piush Srivastava, Sandeep Kumar, Subhasis Das, Sunil Kumar Singh, Daniel R. Principe, Ajay Rana, Basabi Rana. Ets1 mediates sorafenib resistance by regulating mitochondrial ROS pathway in hepatocellular carcinoma. Cell Death & Disease 2022; 13(7) doi: 10.1038/s41419-022-05022-1
|
| 30 |
Shiping Hu, Yun Ran, Wenlin Chen, Yuncheng Zhang, Yongjian Xu. MicroRNA-326 inhibits cell proliferation and invasion, activating apoptosis in hepatocellular carcinoma by directly targeting LIM and SH3 protein 1. Oncology Reports 2017; 38(3) doi: 10.3892/or.2017.5810
|
| 31 |
Jing Hu, Jing Zhang, Feifei Sun, Mei Qi, Peng Su, Hui Liu, Lin Gao, Meng Jiao, Zhen Wu, Lei Xiang, Bo Han. Enhancer of zeste 2 polycomb repressive complex 2 subunit promotes sorafenib resistance of hepatocellular carcinoma though insulin-like growth factor 1 receptor. Anti-Cancer Drugs 2019; 30(7) doi: 10.1097/CAD.0000000000000746
|
| 32 |
Michelle Meier, Anders Riegels Knudsen, Kasper Jarlhelt Andersen, Niels Christian Bjerregaard, Uffe Birk Jensen, Frank Viborg Mortensen. Gene Expression in the Liver Remnant Is Significantly Affected by the Size of Partial Hepatectomy: An Experimental Rat Study. Gene Expression 2017; 17(4) doi: 10.3727/105221617X695825
|
| 33 |
Phuriwat Khiewkamrop, Pattamaphron Phunsomboon, Lysiane Richert, Dumrongsak Pekthong, Piyarat Srisawang. Epistructured catechins, EGCG and EC facilitate apoptosis induction through targeting de novo lipogenesis pathway in HepG2 cells. Cancer Cell International 2018; 18(1) doi: 10.1186/s12935-018-0539-6
|
| 34 |
Christina Schraml, Sascha Kaufmann, Hansjoerg Rempp, Roland Syha, Dominik Ketelsen, Mike Notohamiprodjo, Konstantin Nikolaou. Imaging of HCC—Current State of the Art. Diagnostics 2015; 5(4) doi: 10.3390/diagnostics5040513
|
| 35 |
. 2025; doi: 10.70675/c8de34e7z1fa6z42cbza183z1e37c1b52362
|
| 36 |
Yanmin Xu, Ji Huang, Leina Ma, Juanjuan Shan, Junjie Shen, Zhi Yang, Limei Liu, Yongli Luo, Chao Yao, Cheng Qian. MicroRNA-122 confers sorafenib resistance to hepatocellular carcinoma cells by targeting IGF-1R to regulate RAS/RAF/ERK signaling pathways. Cancer Letters 2016; 371(2) doi: 10.1016/j.canlet.2015.11.034
|
| 37 |
Roberto Ballarin, Alessandro Cucchetti, Francesco Paolo Russo, Paolo Magistri, Matteo Cescon, Umberto Cillo, Patrizia Burra, Antonio Daniele Pinna, Fabrizio Di Benedetto. Long term follow-up and outcome of liver transplantation from hepatitis B surface antigen positive donors. World Journal of Gastroenterology 2017; 23(12): 2095-2105 doi: 10.3748/wjg.v23.i12.2095
|
| 38 |
Daniel R. Rice, J. Madison Hyer, Adrian Diaz, Timothy M. Pawlik. End-of-Life Hospice Use and Medicare Expenditures Among Patients Dying of Hepatocellular Carcinoma. Annals of Surgical Oncology 2021; 28(9) doi: 10.1245/s10434-021-09606-7
|
| 39 |
MINORU TOMIZAWA, FUMINOBU SHINOZAKI, YASUFUMI MOTOYOSHI, TAKAO SUGIYAMA, SHIGENORI YAMAMOTO, NAOKI ISHIGE. Suppression of hepatocellular carcinoma cell proliferation by short hairpin RNA of frizzled 2 with Sonazoid-enhanced irradiation. International Journal of Oncology 2016; 48(1) doi: 10.3892/ijo.2015.3259
|
| 40 |
Lili Zhong, Chenhui Hou, Liang Zhang, Jianchun Zhao, Feng Li, Wenbao Li. Synthesis of deuterium-enriched sorafenib derivatives and evaluation of their biological activities. Molecular Diversity 2019; 23(2) doi: 10.1007/s11030-018-9875-7
|
| 41 |
Shalini V. Gowda, Na Young Kim, Kachigere B. Harsha, Darshini Gowda, Rajaghatta N. Suresh, Amudha Deivasigamani, Chakrabhavi Dhananjaya Mohan, Kam Man Hui, Gautam Sethi, Kwang Seok Ahn, Kanchugarakoppal S. Rangappa. A new 1,2,3-triazole-indirubin hybrid suppresses tumor growth and pulmonary metastasis by mitigating the HGF/c-MET axis in hepatocellular carcinoma. Journal of Advanced Research 2025; 73 doi: 10.1016/j.jare.2024.08.033
|
| 42 |
Peng-Yuan Zhuang, Ke-Wei Zhang, Jian-Dong Wang, Xue-Ping Zhou, Ying-Bin Liu, Zhi-Wei Quan, Jun Shen. Effect of TALEN-mediated IL-6 knockout on cell proliferation, apoptosis, invasion and anti-cancer therapy in hepatocellular carcinoma (HCC-LM3) cells. Oncotarget 2017; 8(44) doi: 10.18632/oncotarget.20946
|
| 43 |
Hong-Yuan Liang, Qi-Yong Guo, Wei Sun, Xiao-Nan Mao, Feng Wen, Ming Shan, Gang Zhao, Xi-Hai Wang, Zai-Ming Lu. Sequential Use of Transhepatic Arterial Chemoembolization and Bipolar Radiofrequency Ablation in the Clinical Therapy of Hepatocellular Carcinoma. Cancer Biotherapy and Radiopharmaceuticals 2015; 30(10) doi: 10.1089/cbr.2015.1884
|
| 44 |
J. Ni, C. Fu, R. Huang, Z. Li, S. Li, P. Cao, K. Zhong, M. Ge, Y. Gao. Metabolic syndrome cannot mask the changes of faecal microbiota compositions caused by primary hepatocellular carcinoma. Letters in Applied Microbiology 2021; 73(1) doi: 10.1111/lam.13477
|
| 45 |
Xinxin Zhang, Jia Yu, Juan Hu, Fang Tan, Juan Zhou, Xiaoyan Yang, Zhizhong Xie, Huifang Tang, Sen Dong, Xiaoyong Lei. 13-lncRNAs Signature to Improve Diagnostic and Prognostic Prediction of Hepatocellular Carcinoma. Combinatorial Chemistry & High Throughput Screening 2021; 24(5) doi: 10.2174/1386207323666200914095616
|
| 46 |
Kyoung A Ko, Hyunwoo Oh, Myung Sub Kim, Hyun Pyo Hong, Yong Kyun Cho, Byung Ik Kim, Won Sohn. Role of ALBI Grade as a Predictive Factor for Long‐Term Mortality in Patients With Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization. Journal of Gastroenterology and Hepatology 2025; 40(11) doi: 10.1111/jgh.70098
|
| 47 |
Wafaa Ahmed, Dina Mofed, Abdel-Rahman Zekri, Nasr El-Sayed, Mohamed Rahouma, Salwa Sabet. Antioxidant activity and apoptotic induction as mechanisms of action of Withania somnifera (Ashwagandha) against a hepatocellular carcinoma cell line. Journal of International Medical Research 2018; 46(4) doi: 10.1177/0300060517752022
|
| 48 |
Min Luo, Huiyan Jiang, Tianyu Shi. Multi-stage puncture path planning algorithm of ablation needles for percutaneous radiofrequency ablation of liver tumors. Computers in Biology and Medicine 2022; 145 doi: 10.1016/j.compbiomed.2022.105506
|
| 49 |
Zhaoxia Sun, Li Zhao, Shuang Wang, Honggang Wang. Knockdown of long non-coding RNA LINC01006 represses the development of hepatocellular carcinoma by modulating the miR-194-5p/CADM1 axis. Annals of Hepatology 2022; 27 doi: 10.1016/j.aohep.2021.100571
|
| 50 |
Xinyang Liu, Zhichao Wang, Zongwei Chen, Longzi Liu, Lijie Ma, Liangqing Dong, Zhao Zhang, Shu Zhang, Liuxiao Yang, Jieyi Shi, Jia Fan, Xiaoying Wang, Qiang Gao. Efficacy and Safety of Transcatheter Arterial Chemoembolization and Transcatheter Arterial Chemotherapy Infusion in Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics 2018; 26(2) doi: 10.3727/096504017X15051752095738
|
| 51 |
Na Zhuang, Zhiyun Gu, Juan Feng, Zixuan Chai, Juanjuan Shan, Cheng Qian. BEX1 mediates sorafenib resistance in hepatocellular carcinoma by regulating AKT signaling. Cellular Signalling 2023; 108 doi: 10.1016/j.cellsig.2023.110722
|
| 52 |
Yousery Nada, Noha Rashad, Mai Eissa, Aya Ghonaim, Kyrillus Farag, Islam Saadawi, Ahmed Sheha, Mahmoud El Gewaity, Omar Abdel-Rahman. Outcomes of treatment with sorafenib in Egyptian patients with hepatocellular carcinoma: a retrospective cohort study. Expert Review of Gastroenterology & Hepatology 2018; 12(1) doi: 10.1080/17474124.2018.1403898
|
| 53 |
Sachin Shetty, Anushree U, Rajesh Kumar, Sanjay Bharati. Electrical conductivity spectra of hepatic tumors reflect hepatocellular carcinoma progression in mice. Biomedical Physics & Engineering Express 2020; 6(6) doi: 10.1088/2057-1976/abbbd5
|
| 54 |
Elisa Salvati, Francesco Stellacci, Silke Krol. Nanosensors for Early Cancer Detection and for Therapeutic Drug Monitoring. Nanomedicine 2015; 10(23) doi: 10.2217/nnm.15.180
|
| 55 |
Xin Li, Jie Yu, Ping Liang, Xiaoling Yu, Zhigang Cheng, Zhiyu Han, Shaobo Duan, Jiasheng Zheng. Ultrasound-guided percutaneous microwave ablation assisted by three-dimensional visualization operative treatment planning system and percutaneous transhepatic cholangial drainage with intraductal chilled saline perfusion for larger hepatic hilum hepatocellular (D ≥ 3 cm): preliminary results. Oncotarget 2017; 8(45) doi: 10.18632/oncotarget.19275
|
| 56 |
Ioannis A Ziogas, Georgios Tsoulfas. Advances and challenges in laparoscopic surgery in the management of hepatocellular carcinoma. World Journal of Gastrointestinal Surgery 2017; 9(12): 233-245 doi: 10.4240/wjgs.v9.i12.233
|
| 57 |
Xiao-Xiao Ding, Qing-Ge Zhu, Shi-Ming Zhang, Lei Guan, Ting Li, Lei Zhang, Shi-Yang Wang, Wan-Li Ren, Xue-Mei Chen, Jing Zhao, Song Lin, Zhi-Zhen Liu, Yan-Xia Bai, Bing He, Hu-Qin Zhang. Precision medicine for hepatocellular carcinoma: driver mutations and targeted therapy. Oncotarget 2017; 8(33) doi: 10.18632/oncotarget.18382
|
| 58 |
Satoshi Kokura. Hyperthermic Oncology from Bench to Bedside. 2016; doi: 10.1007/978-981-10-0719-4_25
|
| 59 |
Eric Waidely, Abdulrahman O. Al-Youbi, Abdulaziz S. Bashammakh, Mohammad S. El-Shahawi, Roger M. Leblanc. Study of the Alpha-l-Fucosidase Langmuir Monolayer at the Air–Water Interface. The Journal of Physical Chemistry B 2016; 120(50) doi: 10.1021/acs.jpcb.6b09094
|
| 60 |
Jing Xie, Aihua Zhang, Xijun Wang. Metabolomic applications in hepatocellular carcinoma: toward the exploration of therapeutics and diagnosis through small molecules. RSC Advances 2017; 7(28) doi: 10.1039/C7RA00698E
|
| 61 |
Sreeram Gourineni, Gaurav Sharma. Targeted Inhibition of Oncogenic p300 Proteins Using Novel PROTACs for Hepatocellular Carcinoma Therapy. 2025 IEEE Integrated STEM Education Conference (ISEC) 2025; doi: 10.1109/ISEC64801.2025.11147406
|
| 62 |
Unlocking the potential of bacteriophage-based therapeutic gene delivery in hepatocellular carcinoma. Journal of the Egyptian National Cancer Institute 2026; 38(1) doi: 10.1186/s43046-026-00406-2
|
| 63 |
Celia Sequera, Sara Manzano, Carmen Guerrero, Almudena Porras. How Rap and its GEFs control liver physiology and cancer development. C3G alterations in human hepatocarcinoma. Hepatic Oncology 2018; 5(1) doi: 10.2217/hep-2017-0026
|
| 64 |
Haijin Huang, Yan‐Zhi Bu, Xiao‐Yu Zhang, Juan Liu, Li‐Yao Zhu, Yong Fang. LINC01433 promotes hepatocellular carcinoma progression via modulating the miR‐1301/STAT3 axis. Journal of Cellular Physiology 2019; 234(5) doi: 10.1002/jcp.27366
|
| 65 |
Keenan Mintz, Eric Waidely, Yiqun Zhou, Zhili Peng, Abdulrahman O. Al-Youbi, Abdulaziz S. Bashammakh, Mohammad S. El-Shahawi, Roger M. Leblanc. Carbon dots and gold nanoparticles based immunoassay for detection of alpha-L-fucosidase. Analytica Chimica Acta 2018; 1041 doi: 10.1016/j.aca.2018.08.055
|
| 66 |
Laura Sneller, Keshav Mathur, Shyam Kottilil, Poonam Mathur. Hot and Cold HCC: Uncoupling Viral Oncogenesis and Therapy. Viruses 2025; 17(9) doi: 10.3390/v17091255
|
| 67 |
Pavan Patel, Steven E Schutzer, Nikolaos Pyrsopoulos. Immunobiology of hepatocarcinogenesis: Ways to go or almost there?. World Journal of Gastrointestinal Pathophysiology 2016; 7(3): 242-255 doi: 10.4291/wjgp.v7.i3.242
|
| 68 |
Chunmei Xie, Christian Tiede, Xuanyi Zhang, Congrong Wang, Zhixiong Li, Xiao Xu, Michael J. McPherson, Darren C. Tomlinson, Weiwen Xu. Development of an Affimer-antibody combined immunological diagnosis kit for glypican-3. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-10083-w
|
| 69 |
Peng-Sheng Yi, Hong Wang, Jian-Shui Li. Evolution and current status of the subclassification of intermediate hepatocellular carcinoma. World Journal of Gastrointestinal Surgery 2020; 12(3): 85-92 doi: 10.4240/wjgs.v12.i3.85
|
| 70 |
Jing Li, Liang Huang, Chao Ge, Xingwu Zhu, Maixuan Qiu, Chaopan Chen, Shaohua Wei, Yiqun Yan. Simultaneous and Sequential Use of Molecular Targeted Agents Plus Immune Checkpoint Inhibitors for Advanced Hepatocellular Carcinoma: A Real-World Practice in China. Journal of Hepatocellular Carcinoma 2023; doi: 10.2147/JHC.S415941
|
| 71 |
Zhengwei Li, Ying Wang. miR-96 targets SOX6 and promotes proliferation, migration, and invasion of hepatocellular carcinoma. Biochemistry and Cell Biology 2018; 96(3) doi: 10.1139/bcb-2017-0183
|
| 72 |
Chou-Yuan Ko, Po-Chang Shih, Po-Wei Huang, Yi-Hsin Lee, Yen-Fu Chen, Ming-Hong Tai, Chi-Hao Liu, Zhi-Hong Wen, Hsiao-Mei Kuo. Sinularin, an Anti-Cancer Agent Causing Mitochondria-Modulated Apoptosis and Cytoskeleton Disruption in Human Hepatocellular Carcinoma. International Journal of Molecular Sciences 2021; 22(8) doi: 10.3390/ijms22083946
|
| 73 |
Michelle Meier, Kasper Jarlhelt Andersen, Anders Riegels Knudsen, Jens Randel Nyengaard, Stephen Hamilton-Dutoit, Frank Viborg Mortensen. Liver regeneration is dependent on the extent of hepatectomy. Journal of Surgical Research 2016; 205(1) doi: 10.1016/j.jss.2016.06.020
|
| 74 |
Mahfoozur Rahman, Waleed H Almalki, Majed Alrobaian, Jawed Iqbal, Saad Alghamdi, Khalid S Alharbi, Nabil K Alruwaili, Abdul Hafeez, Adil Shaharyar, Tanuja Singh, Mohammad Waris, Vikas Kumar, Sarwar Beg. Nanocarriers-loaded with natural actives as newer therapeutic interventions for treatment of hepatocellular carcinoma. Expert Opinion on Drug Delivery 2021; 18(4) doi: 10.1080/17425247.2021.1854223
|
| 75 |
Mengxuan Lu, Xia Kong, Huaigao Wang, Guoliang Huang, Caiguo Ye, Zhiwei He. A novel microRNAs expression signature for hepatocellular carcinoma diagnosis and prognosis. Oncotarget 2017; 8(5) doi: 10.18632/oncotarget.14452
|
| 76 |
MINORU TOMIZAWA, FUMINOBU SHINOZAKI, YASUFUMI MOTOYOSHI, TAKAO SUGIYAMA, SHIGENORI YAMAMOTO, NAOKI ISHIGE. Suppressive effects of 3-bromopyruvate on the proliferation and the motility of hepatocellular carcinoma cells. Oncology Reports 2016; 35(1) doi: 10.3892/or.2015.4370
|
| 77 |
Xiangrui Meng, Peng Lu, Qingxia Fan. RETRACTED: miR-367 promotes proliferation and invasion of hepatocellular carcinoma cells by negatively regulating PTEN. Biochemical and Biophysical Research Communications 2016; 470(1) doi: 10.1016/j.bbrc.2016.01.025
|
| 78 |
Claudia Conte, Sara Maiolino, Diogo Silva Pellosi, Agnese Miro, Francesca Ungaro, Fabiana Quaglia. Light-Responsive Nanostructured Systems for Applications in Nanomedicine. Topics in Current Chemistry 2016; 370 doi: 10.1007/978-3-319-22942-3_3
|
| 79 |
Meiwan Chen, Xingzhi Zhou, Ruie Chen, Junlin Wang, Richard D. Ye, Yitao Wang, Chuanbin Wu, Ram I. Mahato. Nano-carriers for delivery and targeting of active ingredients of Chinese medicine for hepatocellular carcinoma therapy. Materials Today 2019; 25 doi: 10.1016/j.mattod.2018.10.040
|
| 80 |
Sahra Perseh, Reza Bafkary, Hossein Salmani, Mohammad Hassan Shahriari, Rassoul Dinarvand, Ismaeil Haririan, Seyedeh Sahar Mojtabazadeh, Sanaz Jamshidfar, Mohammad Akrami. Dual‐Targeted, pH/Reduction‐Responsive Mesoporous Silica Nanocarriers for Selective Sorafenib Delivery to Hepatocellular Carcinoma. Advanced Therapeutics 2026; 9(8) doi: 10.1002/adtp.202500581
|
| 81 |
Su-Hong Chen, Dan-Dan Xu, Peng-Jun Zhou, Yao Wang, Qiu-Ying Liu, Zhe Ren, Zhong Liu, Xia Wang, Hui-Qing Huang, Xue Xue, Ying Wang, Yi-Fei Wang. Combination treatment with sorafenib and wh‑4 additively suppresses the proliferation of liver cancer cells. Experimental and Therapeutic Medicine 2022; 23(3) doi: 10.3892/etm.2022.11156
|
| 82 |
Indu Priya Gudivada, Krishna Chaitanya Amajala. Integrative Bioinformatics Analysis for Targeting Hub Genes in Hepatocellular Carcinoma Treatment. Current Genomics 2025; 26(1) doi: 10.2174/0113892029308243240709073945
|
| 83 |
Fang Lei, Yongxia Xiong, Yuqing Wang, Honghua Zhang, Ziyi Liang, Junfang Li, Yiyue Feng, Xiangyong Hao, Zhen Wang. Design, Synthesis, and Biological Evaluation of Novel Evodiamine Derivatives as Potential Antihepatocellular Carcinoma Agents. Journal of Medicinal Chemistry 2022; 65(11) doi: 10.1021/acs.jmedchem.2c00520
|
| 84 |
Qian Ding, Xiang-Guo Tian, Yan Li, Qi-Zhi Wang, Chun-Qing Zhang. Carvedilol may attenuate liver cirrhosis by inhibiting angiogenesis through the VEGF-Src-ERK signaling pathway. World Journal of Gastroenterology 2015; 21(32): 9566-9576 doi: 10.3748/wjg.v21.i32.9566
|
| 85 |
Recep Erçin SÖNMEZ, Florent L. BESSON, Jerome GHİDAGLIA, Maïté LEWIN, Lea GOMEZ, Chady SALLOUM, Gabriella PITTAU, Oriana CIACIO, Marc Antoine ALLARD, Daniel CHERQUI, René ADAM, Antonio SA CUNHA, Daniel AZOULAY, Eric VİBERT, Nicolas GOLSE. Towards refining the utility of dual (18F-FDG / 18F-Choline) PET/CT for the management of hepatocellular carcinoma: a tertiary center study. The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2023; 67(3) doi: 10.23736/S1824-4785.22.03485-9
|
| 86 |
Liying Guo, Kai Tan, Hao Wang, Xuan Zhang. Pterostilbene inhibits hepatocellular carcinoma through p53/SOD2/ROS-mediated mitochondrial apoptosis. Oncology Reports 2016; 36(6) doi: 10.3892/or.2016.5151
|
| 87 |
Li Xu, Yuanrun Zhu, Jinjin Shao, Min Chen, Hao Yan, Guanqun Li, Yi Zhu, Zhifei Xu, Bo Yang, Peihua Luo, Qiaojun He. Dasatinib synergises with irinotecan to suppress hepatocellular carcinoma via inhibiting the protein synthesis of PLK1. British Journal of Cancer 2017; 116(8) doi: 10.1038/bjc.2017.55
|
| 88 |
Kai-Po Chang, Shih-Huan Lin, Yen-Wei Chu. Artificial intelligence in gastrointestinal radiology: A review with special focus on recent development of magnetic resonance and computed tomography. Artificial Intelligence in Gastroenterology 2021; 2(2): 27-41 doi: 10.35712/aig.v2.i2.27
|
| 89 |
Ruoxiu Xiao, Xiaoheng Li, Ming-an Yu, Tong Lu, Zhenlong Zhao, Jie Wu, Cheng Chen. Puncture path planning for thermal ablation surgery of hyperparathyroidism based on multi-objective constraints. Biomedical Signal Processing and Control 2026; 120 doi: 10.1016/j.bspc.2026.109998
|
| 90 |
Shilong Han, Murong Li, Zixuan Liu, Yulan Liu, Lei Wang, Yong Lei. Path Planning for Flexible Needles Based on Multi-Agent Deep Reinforcement Learning. 2025 IEEE/ASME International Conference on Advanced Intelligent Mechatronics (AIM) 2025; doi: 10.1109/AIM64088.2025.11175734
|
| 91 |
Eric Waidely, Abdulrahman O. Al-Youbi, Abdulaziz S. Bashammakh, Mohammad S. El-Shahawi, Roger M. Leblanc. Alpha-l-Fucosidase Immunoassay for Early Detection of Hepatocellular Carcinoma. Analytical Chemistry 2017; 89(17) doi: 10.1021/acs.analchem.7b02284
|
| 92 |
Lina Wang, Qin Ding, Li Zhao, Yu Pan, Zhengxia Song, Yanan Qin, Xuebing Yan. Decreased BMP‑7 and p‑Smad1/5/8 expression, and increased levels of gremlin in hepatocellular carcinoma. Oncology Letters 2018; doi: 10.3892/ol.2018.8918
|
| 93 |
Can Kamali, Kaan Kamali, Philipp Brunnbauer, Katrin Splith, Johann Pratschke, Moritz Schmelzle, Felix Krenzien. Extended liver resection in mice: state of the art and pitfalls—a systematic review. European Journal of Medical Research 2021; 26(1) doi: 10.1186/s40001-020-00478-3
|
| 94 |
Xu Zhao, Jian Hao, Sinuan Chen, George B. Lenon. Network Pharmacology‐Based Strategy for Predicting Therapy Targets of Traditional Chinese Medicine Xihuang Pill on Liver Cancer. Evidence-Based Complementary and Alternative Medicine 2020; 2020(1) doi: 10.1155/2020/6076572
|
| 95 |
Masaki Kaibori, Kazuko Sakai, Morihiko Ishizaki, Hideyuki Matsushima, Marco A. De Velasco, Kosuke Matsui, Hiroya Iida, Hiroaki Kitade, A-Hon Kwon, Hiroaki Nagano, Hiroshi Wada, Seiji Haji, Tadashi Tsukamoto, Akishige Kanazawa, Yutaka Takeda, Shigekazu Takemura, Shoji Kubo, Kazuto Nishio. Increased FGF19 copy number is frequently detected in hepatocellular carcinoma with a complete response after sorafenib treatment. Oncotarget 2016; 7(31) doi: 10.18632/oncotarget.10077
|
| 96 |
Chengyong Liu, Chunying Wang, Ji Wang, Haibin Huang. miR-1297 promotes cell proliferation by inhibiting RB1 in liver cancer. Oncology Letters 2016; 12(6) doi: 10.3892/ol.2016.5326
|
| 97 |
Hao Xie, Diego M Alem Glison, Richard D. Kim. FGFR4 inhibitors for the treatment of hepatocellular carcinoma: a synopsis of therapeutic potential. Expert Opinion on Investigational Drugs 2022; 31(4) doi: 10.1080/13543784.2022.2017879
|
| 98 |
Roberto Mazzanti, Umberto Arena, Renato Tassi. Hepatocellular carcinoma: Where are we?. World Journal of Experimental Medicine 2016; 6(1): 21-36 doi: 10.5493/wjem.v6.i1.21
|
| 99 |
Shunyan Weng, Liang Zhou, Qing Deng, Jiaxian Wang, Yan Yu, Jianwei Zhu, Yunsheng Yuan. Niclosamide induced cell apoptosis via upregulation of ATF3 and activation of PERK in Hepatocellular carcinoma cells. BMC Gastroenterology 2016; 16(1) doi: 10.1186/s12876-016-0442-3
|
| 100 |
Xiang Chen, Gui Zhou, Lihang Cen, Shuang Qin, Meiyu Dai. The miR-4512/PDZK1IP1 axis in hepatocellular carcinoma: clinical significance, diagnostic value, and functional validation. BMC Medical Genomics 2026; 19(1) doi: 10.1186/s12920-026-02399-2
|
| 101 |
MINORU TOMIZAWA, FUMINOBU SHINOZAKI, YASUFUMI MOTOYOSHI, TAKAO SUGIYAMA, SHIGENORI YAMAMOTO, NAOKI ISHIGE. FH535 suppresses the proliferation and motility of hepatocellular carcinoma cells. International Journal of Oncology 2016; 48(1) doi: 10.3892/ijo.2015.3220
|
| 102 |
Kyeong Hwa Sim, Mi-Sun Shu, Soyoung Kim, Jong-Yeon Kim, Bo-Hyun Choi, Youn Ju Lee. Cilostazol Induces Apoptosis and Inhibits Proliferation of Hepatocellular Carcinoma Cells by Activating AMPK. Biotechnology and Bioprocess Engineering 2021; 26(5) doi: 10.1007/s12257-021-0002-8
|